Shiraz Institute for Cancer Research, opened in June 1998, is located on Shiraz School of medicine main campus at Zand Avenue. The institute is the first nation’s comprehensive center in which both immunological and biological aspects of cancer are under investigation.
Read more about us
 

Feature Slides

Our affiliation

Shiraz Institute for Cancer Research (ICR)
School of Medicine
Shiraz University of Medical Sciences
P.O. Box: 71345-3119
Email: icr@sums.ac.ir
 
Useful links





 




 



 
 



Call for grant

Interested academics and post-graduated students are
requested to visit the following website for grant application: http://web-sa.ir/


 
Postdoctoral Research Fellowship

Up to two postdoctoral fellows are now available at Shiraz Institute for Cancer Research under supervision of Dr. Ghaderi, ICR director. For more information, please contact to Dr. Ghaderi at ghaderia@sums.ac.ir

Journal Clubs and Seminars

The journal clubs or seminars meet regularly every two weeks for one hour, 8:30-9:30 A.M. on Sunday in lecture room, to review current research about clinical practice especially in the field of cancer research. ...

Highly cited papers

      1. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)(citations)

2. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit ( citations)
3. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. (
citations
)

4. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma ( citations)

4.
Cytotoxic T lymphocyte antigen-4 gene in breast cancer (citations)

5.
The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors (citations)

6. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express .... ( citations)



New publications

 

1. Abtahi S, Asadipour M, Ghaderi A. The Legacy of Mesenchymal Stem Cells in Vindicating the Clonal Evolution Model of Cancer. Asian Pacific journal of cancer prevention : APJCP. 2018;19(8):2029-30.

 2. Mehdipour F, Razmkhah M, Rezaeifard S, Bagheri M, Talei AR, Khalatbari B, et al. Mesenchymal stem cells induced anti-inflammatory features in B cells from breast tumor draining lymph nodes. Cell biology international. 2018. doi: 10.1002/cbin.11062
 
3.  Ghaderi F, Ahmadvand S, Ramezani A, Montazer M, Ghaderi A. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line. Biochemical and biophysical research communications. 2018;505(1):181-6.

4. Faghih Z, Deihimi S, Talei A, Ghaderi A, Erfani N. Analysis of T cell receptor repertoire based on Vbeta chain in patients with breast cancer. Cancer biomarkers : section A of Disease markers. 2018;22(4):733-45.

5.  Razmkhah M, Abtahi S, Ghaderi A. Mesenchymal stem cells, immune cells and tumor cells cross talk: A sinister triangle in the tumor microenvironment. Current stem cell research & therapy. 2018.
doi: 10.2174/1574888X13666180816114809

 

 Find all published papers here...
 
 
 
 
 
 
 

 



  News

Breast cancer congress
6/15/15
28-30 October 2015, Tehran, Iran
Journal club on 26th Farvardin
4/14/15
Cell therapy in cancer
4th European Congress of Immunology (ECI);Vienna 2015
3/2/15
6-9 September 2015 in Vienna. Abstract deadline of 30 April 2015